Inside the UK’s new psychedelic drug trial clinic trying to treat depression and anxiety
Interest in psilocybin as treatment is growing, and this month Europe’s first commercial facility for psychedelic trials opens in London
Roullier describes the ordeal as a visceral and challenging exercise. During his hallucinatory trip he engaged with feelings and emotions he had been avoiding for years. “It was a Wizard of Oz moment,” Roullier recalls. “That doesn’t mean that everything was rosy and beautiful, but my anxiety and depression had lifted. I approached situations openly, the self doubt, and self recrimination in my head had faded away.”
No comments:
Post a Comment